Anti-PCD15/ PCDH15/ CDHR15 monoclonal antibody

Anti-PCD15/ PCDH15/ CDHR15 antibody for FACS & in-vivo assay

Target products collectionGo to PCDH15/PCDH15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1329-Ab-1/ GM-Tg-hg-MP1329-Ab-2Anti-Human PCDH15 monoclonal antibodyHuman
GM-Tg-rg-MP1329-Ab-1/ GM-Tg-rg-MP1329-Ab-2Anti-Rat PCDH15 monoclonal antibodyRat
GM-Tg-mg-MP1329-Ab-1/ GM-Tg-mg-MP1329-Ab-2Anti-Mouse PCDH15 monoclonal antibodyMouse
GM-Tg-cynog-MP1329-Ab-1/ GM-Tg-cynog-MP1329-Ab-2Anti-Cynomolgus/ Rhesus macaque PCDH15 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1329-Ab-1/ GM-Tg-felg-MP1329-Ab-2Anti-Feline PCDH15 monoclonal antibodyFeline
GM-Tg-cang-MP1329-Ab-1/ GM-Tg-cang-MP1329-Ab-2Anti-Canine PCDH15 monoclonal antibodyCanine
GM-Tg-bovg-MP1329-Ab-1/ GM-Tg-bovg-MP1329-Ab-2Anti-Bovine PCDH15 monoclonal antibodyBovine
GM-Tg-equg-MP1329-Ab-1/ GM-Tg-equg-MP1329-Ab-2Anti-Equine PCDH15 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1329-Ab-1/ GM-Tg-hg-MP1329-Ab-2; GM-Tg-rg-MP1329-Ab-1/ GM-Tg-rg-MP1329-Ab-2;
GM-Tg-mg-MP1329-Ab-1/ GM-Tg-mg-MP1329-Ab-2; GM-Tg-cynog-MP1329-Ab-1/ GM-Tg-cynog-MP1329-Ab-2;
GM-Tg-felg-MP1329-Ab-1/ GM-Tg-felg-MP1329-Ab-2; GM-Tg-cang-MP1329-Ab-1/ GM-Tg-cang-MP1329-Ab-2;
GM-Tg-bovg-MP1329-Ab-1/ GM-Tg-bovg-MP1329-Ab-2; GM-Tg-equg-MP1329-Ab-1/ GM-Tg-equg-MP1329-Ab-2
Products NameAnti-PCDH15 monoclonal antibody
Formatmab
Target NamePCDH15
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PCDH15 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PCD15/ PCDH15/ CDHR15 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1329
    Target NamePCDH15
    Gene ID65217,11994,690865,702413,609280,101088616,100140108,100071973
    Gene Symbol and Synonymsav,CDHR15,DFNB23,Gm9815,nmf19,PCDH15,roda,USH1F
    Uniprot AccessionQ96QU1
    Uniprot Entry NamePCD15_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000150275
    Target ClassificationN/A

    The target: PCDH15, gene name: PCDH15, also named as CDHR15, DFNB23, USH1F. This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.